Evaluating Dietary Interventions for the Management of Multiple Sclerosis

Multiple sclerosis (MS) is a neurodegenerative and inflammatory disease that affects about 2.5 million people worldwide. There are many medical and nutritional interventions. Some of the accepted drug approaches include an immunomodulatory agent such as Glatiramer aceate, anti-inflammatory compounds Interferon-β1a and β1b, and substances that attenuate disease progression, including natalizumab and mitoxantrone (National Multiple Sclerosis Society, 2008). More recently, short-term pilot studies …